SCHEMBL22108342

SCHEMBL22108342

Cc1nc(-c2nnn(C)c2CO)cnc1OC1CCCCC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SLCO1B1 Q9Y6L6 5/20 0.52
▸ ABCB11 O95342 3/20 0.52
▸ ABCC3 O15438 2/20 0.37
▸ ABCC4 O15439 2/20 0.37
▸ SLCO1B3 Q9NPD5 2/20 0.37
▸ LPAR1 Q92633 1/20 0.37
▸ FFAR4 Q5NUL3 1/20 0.35
▸ BRD4 O60885 1/20 0.33
▸ FPR2 P25090 2/20 0.32
▸ PROKR1 Q8TCW9 2/20 0.32
▸ HRH4 Q9H3N8 1/20 0.32
▸ LRRK2 Q5S007 2/20 0.31
▸ NMT1 P30419 1/20 0.31
▸ PIK3CD O00329 1/20 0.30
▸ HDAC3 O15379 2/20 0.30
▸ CDK9 P50750 2/20 0.30
▸ HDAC1 Q13547 2/20 0.30
▸ HDAC6 Q9UBN7 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30460151 0.88 SLCO1B1 (0.42) SLCO1B1ABCB11ABCC3ABCC4SLCO1B3
SCHEMBL19715489 0.85 SLCO1B1 (0.71) SLCO1B1ABCB11ABCC3ABCC4SLCO1B3
SCHEMBL29411772 0.81 SLCO1B1 (0.58) SLCO1B1ABCB11ABCC3ABCC4SLCO1B3
SCHEMBL28631662 0.81 SLCO1B1 (0.56) SLCO1B1ABCB11ABCC3ABCC4SLCO1B3
SCHEMBL21807864 0.81 SLCO1B1 (0.56) SLCO1B1ABCB11ABCC3ABCC4SLCO1B3
SCHEMBL22108733 0.81 SLCO1B1 (0.48) SLCO1B1ABCB11ABCC3ABCC4SLCO1B3
SCHEMBL22108233 0.81 SLCO1B1 (0.66) SLCO1B1ABCB11ABCC3ABCC4SLCO1B3
SCHEMBL22108262 0.81 SLCO1B1 (0.66) SLCO1B1ABCB11ABCC3ABCC4SLCO1B3
SCHEMBL21796139 0.81 SLCO1B1 (0.48) SLCO1B1ABCB11ABCC3ABCC4SLCO1B3
SCHEMBL23863735 0.80 SLCO1B1 (0.79) SLCO1B1ABCB11ABCC3ABCC4SLCO1B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3666771-B1 LPA ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2021-09-29 — — EP disclosed
EP-3666771-A1 LPA ANTAGONISTS Bristol-Myers Squibb Company (US) 2020-06-17 — — EP disclosed
Send feedback